High prevalence of gouty arthritis among the hmong population in Minnesota

Arthritis Care and Research

Volumn 62, Issue 10, 2010, Pages 1386-1391

  Portis, Andrew J ^a   Laliberte, Mark ^a   Tatman, Penny ^a   Moua, Maikia ^a   Culhane Pera, Kathleen ^b   Maalouf, Naim M ^c   Sakhaee, Khashayar ^c  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b West Side Community Health Services   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; COMMUNITY ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; GOUT; HEALTH SURVEY; HUMAN; INDUSTRIALIZATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNITED STATES; ARTHRITIS, GOUTY; ASIAN AMERICAN; ETHNOLOGY; LAOS; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, GOUTY; ASIAN AMERICANS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LAOS; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE;

EID: 77957672672     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20232     Document Type: Article

References (40)

1. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42.
2. Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 1992;51:375-7.
3. Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, Rich SS, et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 2000;106:355-9.
4. Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol 2007;3:443-9.
5. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141:637-44.
6. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-21.
7. Terkeltaub RA. Clinical practice: gout. N Engl J Med 2003;349:1647-55.
8. Schlesinger N, Schumacher HR Jr. Gout: can management be improved? Curr Opin Rheumatol 2001;13:240-4.
9. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:7-13.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
11. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6.
12. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998;37:258-62.
13. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan's aborigines. J Rheumatol 1997;24:1364-9.
14. Portis AJ, Hermans K, Culhane-Pera KA, Curhan GC. Stone disease in the Hmong of Minnesota: initial description of a high-risk population. J Endourol 2004;18:853-7. (Pubitemid 39627563)
15. Centers for Disease Control and Prevention, US Department of Health and Human Services. National Health and Nutrition Examination Survey. 2007. URL: http://www.cdc.gov/nchs/nhanes.htm.
16. Culhane-Pera KA, Xiong P. Hmong culture: tradition and change. In: Culhane-Pera KA, Vawter DE, Xiong P, Babbitt B, Solberg MM, editors. Healing by heart: clinical and ethical case stories of Hmong families and Western providers. Nashville: Vanderbilt University Press; 2003. p. 11-68.
17. Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br J Rheumatol 1984;23:276-82.
18. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28:1640-6.
19. Prior IA, Rose BS, Harvey HP, Davidson F. Hyperuricaemia, gout, and diabetic abnormality in Polynesian people. Lancet 1966;1:333-8.
20. Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994;33:932-7. (Pubitemid 24324808)
21. Chang FT, Chang SJ, Wu YY, Wang TN, Ko YC. Body mass index and hyperuricemia differences between aboriginal and non-aboriginal children in Taiwan. Gaoxiong Yi Xue Ke Xue Za Zhi 1995;11:315-21.
22. Chen KT, Chen CJ, Gregg EW, Engelgau MM, Narayan KM. Prevalence of type 2 diabetes mellitus in Taiwan: ethnic variation and risk factors. Diabetes Res Clin Pract 2001;51:59-66.
23. Tsai HC, Tseng WP, Yen TS, Cheng JT, Wang LT, Hsieh YY, et al. Coronary heart disease and hypertension in Taiwan aborigines. Am J Epidemiol 1967;86:253-63.
24. Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi Nhi C, Ngoc An T. Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 2003;30:2252-6.
25. Ikeda JP. Hmong American food practices, customs, and holidays. 2nd ed. Chicago: American Diabetes Association; 1999.
26. Yang RC, Mills PK. Dietary and lifestyle practices of Hmong in California. J Health Care Poor Underserved 2008;19:1258-69.
27. Munger RG, Gomez-Marin O, Prineas RJ, Sinaiko AR. Elevated blood pressure among Southeast Asian refugee children in Minnesota. Am J Epidemiol 1991;133:1257-65.
28. Himes JH, Story M, Czaplinski K, Dahlberg-Luby E. Indications of early obesity in low-income Hmong children. Am J Dis Child 1992;146:67-9.
29. Her C, Mundt M. Risk prevalence for type 2 diabetes mellitus in adult Hmong in Wisconsin: a pilot study. WMJ 2005;104:70-7. (Pubitemid 43150928)
30. Pfeifer ME, Lee S. Hmong population, demographic, socioeconomic, and educational trends in the 2000 census. In: Thao B, Schein L, Niedzweicki M, editors. Hmong 2000 census publication: data and analysis. Washington, DC: Hmong National Development, Inc.; 2004. p. 3-11.
31. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol 2005;25:3-8. (Pubitemid 40128142)
32. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
33. Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh) 1977;85:198-208. (Pubitemid 8087786)
34. Kehoe R, Wu SY, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol 1994;139:813-8.
35. Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol 2004;19:411-6.
36. Harrold LR, Saag KS, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, et al. Validity of gout diagnoses in administrative data. Arthritis Rheum 2007;57:103-8. (Pubitemid 46256731)
37. Malik A, Dinnella JE, Kwoh CK, Schumacher HR. Poor validation of medical record ICD-9 diagnoses of gout in a veterans affairs database. J Rheumatol 2009;36:1283-6.
38. Mills RJ. Health insurance coverage. Washington, DC: US Government Printing Office; 2001.
39. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642-50. (Pubitemid 39237608)
40. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.